Zoetis Inc. ( ZTS) - Stock Earnings
ZTS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 721.0 million USD | 2.4 billion USD |
| 2025Q4 | 603.0 million USD | 2.4 billion USD |
| 2026Q1 | 601.0 million USD | 2.3 billion USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
ZTS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 2.3 billion USD | 8.5 billion USD |
| 2024 | 2.5 billion USD | 9.3 billion USD |
| 2025 | 2.7 billion USD | 9.5 billion USD |
| 2026 Est. | — | — |
ZTS
List: Contenders
Price: $80.17
Dividend Yield: 2.65%
Forward Dividend Yield: 2.67%
Payout Ratio: 33.88%
Dividend Per Share: 2.12 USD
Earnings Per Share: 6.10 USD
P/E Ratio: 12.19
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 1.6 million
Ebitda: 543.0 millionMarket Capitalization: 32.5 billion
Average Dividend Frequency: 4
Years Paying Dividends: 14
DGR3: 17.50%
DGR5: 20.78%
DGR10: 19.77%